Boston Scientific in €26m Clonmel investment
Boston Scientific is to invest €26m in research and development at its Clonmel facility, the company announced today.
The investment is supported by the Government through IDA Ireland and will enable Boston Scientific to significantly expand its R&D and technical capabilities related to the design of the company’s next-generation cardiac rhythm management devices manufactured at the Clonmel facility.
“R&D investments by leading multinationals like Boston Scientific not only create high-value jobs, but also provide substantial spin-off benefits for Irish businesses, researchers and ultimately the economy," said Enterprise Minister Richard Bruton.
"This investment is great news for Clonmel, and we must seize this opportunity to ensure that investments like this can be replicated across the country to create jobs and get the economy growing again.”
Boston Scientific established operations in Ireland in 1994 and is one of the country’s largest employers, with campuses in Clonmel, Galway and Cork.
